Alfarsi, Lutfi H.
El Ansari, Rokaya
Craze, Madeleine L.
Masisi, Brendah K.
Ellis, Ian O.
Rakha, Emad A.
Green, Andrew R. http://orcid.org/0000-0002-0488-5913
Article History
Received: 24 February 2020
Accepted: 7 May 2020
First Online: 14 May 2020
Ethics approval and consent to participate
: This study was performed according to the REMARK guidelines for tumour prognostic studies [CitationRef removed], and approved by the Nottingham Research Ethics Committee 2 under the title “Development of a molecular genetic classification of breast cancer”. All samples from Nottingham used in this study were pseudo-anonymised and collected prior to 2006 and therefore under the Human Tissue Act informed patient consent was not needed. Release of data was also pseudo-anonymised as per Human Tissue Act regulations.
: Not applicable.
: The authors declare that they have no competing interests.